Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 29.00
-0.54 (-1.83%)
At close: Aug 24, 2026
SHA:688139 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,430 | 2,329 | 2,284 | 2,281 | 2,864 | 2,126 |
Revenue Growth | 7.70% | 1.96% | 0.13% | -20.36% | 34.72% | 51.63% |
Gross Profit Gross Profit Growth | 1,142 | 1,082 | 1,094 | 1,107 | 1,374 | 1,065 |
Operating Income Operating Income Growth | 222.42 | 195.77 | 306.58 | 312.95 | 564.67 | 441.98 |
Net Income Net Income Growth | 255.41 | 250.73 | 366.63 | 406.07 | 600.79 | 845.04 |
Earnings Per Share EPS Growth | 0.82 | 0.80 | 1.16 | 1.28 | 1.89 | 2.66 |
EPS Growth | -5.74% | -31.03% | -9.38% | -32.27% | -28.95% | 127.35% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Mainland China Mainland China Growth | 1,480 | 1,564 | 1,495 | 2,030 |
Others Others Growth | 848.27 | 719.91 | 786.12 | 833.9 |
Total Total Growth | 2,329 | 2,284 | 2,281 | 2,864 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,551 | 1,291 | 1,778 | 1,920 | 2,975 | 2,904 |
Total Debt Total Debt Growth | 12.94 | 29.55 | 23.2 | 18.11 | 26.15 | 5.97 |
Net Cash (Debt) Net Cash Growth | 1,538 | 1,262 | 1,755 | 1,902 | 2,949 | 2,898 |
Net Cash Growth | 8.68% | -28.11% | -7.73% | -35.50% | 1.76% | 29.86% |
Net Cash Per Share Net Cash Per Share Growth | 4.94 | 4.03 | 5.55 | 6.00 | 9.28 | 9.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 376.53 | 267.89 | 291.67 | 249.26 | 632.43 | 591.8 |
Capital Expenditures CapEx Growth | -86.65 | -119.25 | -126.7 | -177.18 | -294.24 | -204.69 |
Free Cash Flow Free Cash Flow Growth | 289.88 | 148.64 | 164.96 | 72.08 | 338.18 | 387.11 |
Free Cash Flow Growth | 107.48% | -9.89% | 128.85% | -78.69% | -12.64% | -36.29% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.00% | 46.45% | 47.89% | 48.53% | 47.97% | 50.08% |
Operating Margin | 9.15% | 8.41% | 13.42% | 13.72% | 19.72% | 20.79% |
Pretax Margin | 10.91% | 11.37% | 17.60% | 19.05% | 23.58% | 45.20% |
Profit Margin | 10.51% | 10.77% | 16.05% | 17.80% | 20.98% | 39.75% |
FCF Margin | 11.93% | 6.38% | 7.22% | 3.16% | 11.81% | 18.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.330 | 0.330 | 0.470 | 0.515 | 0.450 | 0.500 |
Dividend Per Share Growth | -29.79% | -29.79% | -8.74% | 14.44% | -10.02% | 31.61% |
Dividend Yield | 1.16% | 1.05% | 1.37% | 1.32% | 0.75% | 0.58% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.38 | 39.58 | 30.31 | 31.58 | 33.42 | 34.08 |
Forward PE | 31.87 | 19.67 | 17.53 | 18.53 | 25.87 | 39.80 |
P/FCF Ratio | 31.18 | 66.77 | 67.36 | 177.91 | 59.37 | 74.39 |
PS Ratio | 3.72 | 4.26 | 4.87 | 5.62 | 7.01 | 13.55 |